A
ARCT
Arcturus Therape
7.66
+0.45+6.24%After Hours: 7.80 +0.14 +1.83%19:51 05/27 EDT
OPEN/PREV CLOSE7.89/7.92
TODAY RANGE7.79-8.05
VOL410.93K
MARKET CAP225.11M
52 WEEK RANGE5.85-24.17
AVG VOL (3M)475.35K
% TURNOVER1.45%
TURNOVER--
P/E (TTM)-2.8126
% RANGE3.16%
EPS(TTM)-2.8159
P/E(FORWARD)-2.0360
P/B1.176
BVPS6.73
DIVIDEND--
P/S2.743
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP207.13M
SHARES OUTSTANDING28.42M
NEXT EARNINGS08/10-08/14
FREE FLOAT26.15M
LOT SIZE1
EX-DATE11/16/2017
News
Press Releases
Financial Reports
Profile
TipRanks·05/20 04:33
Arcturus Therapeutics’ Earnings Call: mRNA Bets vs. Burn
TipRanks·05/09 01:17
Arcturus Therapeutics Signals Progress Amid Revenue Slip
Seeking Alpha·05/08 04:32
Arcturus outlines 12-week ARCT-032 Phase II enrollment and extends cash runway beyond Q2 2028
TipRanks·05/07 21:28
Arcturus Therapeutics Reports Q1 Results, Advances Rare Disease Pipeline
Benzinga·05/07 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
Reuters·05/07 20:09
Arcturus Therapeutics Q1 revenue drops sharply, net loss widens
Seeking Alpha·05/07 20:05
Arcturus Therapeutics GAAP EPS of -$0.95 beats by $0.04, revenue of $2.06M misses by $4.81M
Dow Jones·05/07 20:01
*Arcturus Therapeutics 1Q Loss $27M >ARCT
Same Industry
Name/Symbol
Change%
Price